Form C-AR — RS BioTherapeutics, Inc.
0001665160-25-000955 · filed 2025-05-02
Offering
- Target
- —
- Maximum
- —
- Security type
- —
- Price per security
- —
- Deadline
- —
- Oversubscription
- —
Issuer
- CIK
- 1932193
- Entity
- Corporation
- Jurisdiction
- DE
- Address
- 157 Baltimore St. Suite 140
Cumberland, MD 21502 - Phone
- —
Most recent fiscal year financials
View original on SEC EDGAR.